Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-01-24

Clinical Trial Update: Study to Evaluate the Improvement Effect on Subjective Symptom of FEXUCLUE Tab

View source ↗

Summary

A completed clinical trial evaluating the improvement of subjective symptoms with FEXUCLUE Tab in gastroesophageal reflux disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FEXUCLUE Tab

Snippet

Sponsor: Daewoong Pharmaceutical Co. LTD. | Conditions: Gastroesophageal Reflux Disease | Status: COMPLETED